ARTV (Artiva Biotherapeutics) FCF Margin %: 0.00% (As of Mar. 2026)


ARTV Artiva Biotherapeutics Inc ARTV
12 GF Score
Price $8.83
! 3 Warning Signs
View Full Analysis

What is Artiva Biotherapeutics FCF Margin %?

Artiva Biotherapeutics ARTV -5.16% 12 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ARTV with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, Artiva Biotherapeutics ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Artiva Biotherapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-21.19 Mil. Artiva Biotherapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Artiva Biotherapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Artiva Biotherapeutics's current FCF Yield % is -18.69%.

The historical rank and industry rank for Artiva Biotherapeutics's FCF Margin % or its related term are showing as below:


During the past 7 years, the highest FCF Margin % of Artiva Biotherapeutics was -151.34%. The lowest was -22180.88%. And the median was -1004.55%.

ARTV's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Artiva Biotherapeutics FCF Margin % Related Terms

Artiva Biotherapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Artiva Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artiva Biotherapeutics FCF Margin % Chart

Artiva Biotherapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -850.55 -1,158.55 -151.34 -22,180.88 0.00

Artiva Biotherapeutics Quarterly Data
Dec19 Dec20 Mar21 Sep21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ARTV vs ENTA, VNDA, VSTM: FCF Margin % Comparison

For the Biotechnology subindustry, Artiva Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artiva Biotherapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artiva Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Artiva Biotherapeutics's FCF Margin % falls into.


ARTV
12GF Score
Artiva Biotherapeutics Inc ARTV
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artiva Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Artiva Biotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-79.338/0
= %

Artiva Biotherapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-21.192/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Artiva Biotherapeutics (ARTV) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Artiva Biotherapeutics and its competitors. According to the industry distribution chart, Artiva Biotherapeutics ranks #999999 out of 960 companies in the Biotechnology industry.
Is Artiva Biotherapeutics' FCF Margin % too high?
Artiva Biotherapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Artiva Biotherapeutics ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Artiva Biotherapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Artiva Biotherapeutics' FCF Margin % compare to ENTA and VNDA?
According to the Biotechnology industry distribution chart, Artiva Biotherapeutics ranks #999999 out of 960 companies for FCF Margin %. This places Artiva Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Artiva Biotherapeutics and its competitors. Artiva Biotherapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artiva Biotherapeutics stock overvalued right now?
Artiva Biotherapeutics (ARTV) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Artiva Biotherapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Artiva Biotherapeutics (ARTV), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artiva Biotherapeutics Business Description

Address 5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
12GF Score

Get the complete analysis for ARTV

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.83
Price